ID   ZN574_HUMAN             Reviewed;         896 AA.
AC   Q6ZN55; Q6IPE0; Q6ZN10; Q7L5Z5; Q8NCE3; Q9H6N0;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 2.
DT   28-JUN-2023, entry version 156.
DE   RecName: Full=Zinc finger protein 574;
GN   Name=ZNF574;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Cerebellum, Hepatoma, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-164; THR-724 AND SER-728, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-164; SER-298; SER-717 AND
RP   SER-728, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-717 AND SER-728, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113 AND SER-164, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-832, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC   -!- INTERACTION:
CC       Q6ZN55-2; Q8NHQ1: CEP70; NbExp=3; IntAct=EBI-17189720, EBI-739624;
CC       Q6ZN55-2; A2VCK2: DCDC2B; NbExp=3; IntAct=EBI-17189720, EBI-10173222;
CC       Q6ZN55-2; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-17189720, EBI-5916454;
CC       Q6ZN55-2; Q9UBR4-2: LHX3; NbExp=3; IntAct=EBI-17189720, EBI-12039345;
CC       Q6ZN55-2; Q5JTD7: LRRC73; NbExp=3; IntAct=EBI-17189720, EBI-12003882;
CC       Q6ZN55-2; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-17189720, EBI-16439278;
CC       Q6ZN55-2; P78424: POU6F2; NbExp=3; IntAct=EBI-17189720, EBI-12029004;
CC       Q6ZN55-2; Q12933: TRAF2; NbExp=3; IntAct=EBI-17189720, EBI-355744;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6ZN55-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ZN55-2; Sequence=VSP_022878;
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK025712; BAB15225.1; -; mRNA.
DR   EMBL; AK074788; BAC11210.1; -; mRNA.
DR   EMBL; AK131369; BAD18520.1; -; mRNA.
DR   EMBL; AK131418; BAD18565.1; -; mRNA.
DR   EMBL; BC001184; AAH01184.2; -; mRNA.
DR   EMBL; BC071962; AAH71962.1; -; mRNA.
DR   CCDS; CCDS12596.1; -. [Q6ZN55-1]
DR   RefSeq; NP_001317448.1; NM_001330519.1.
DR   RefSeq; NP_073589.4; NM_022752.5. [Q6ZN55-1]
DR   RefSeq; XP_005259216.1; XM_005259159.2. [Q6ZN55-1]
DR   RefSeq; XP_011525530.1; XM_011527228.2. [Q6ZN55-1]
DR   RefSeq; XP_011525531.1; XM_011527229.2. [Q6ZN55-1]
DR   RefSeq; XP_011525532.1; XM_011527230.2. [Q6ZN55-1]
DR   AlphaFoldDB; Q6ZN55; -.
DR   SMR; Q6ZN55; -.
DR   BioGRID; 122276; 287.
DR   IntAct; Q6ZN55; 46.
DR   MINT; Q6ZN55; -.
DR   STRING; 9606.ENSP00000469029; -.
DR   iPTMnet; Q6ZN55; -.
DR   PhosphoSitePlus; Q6ZN55; -.
DR   BioMuta; ZNF574; -.
DR   DMDM; 125991263; -.
DR   EPD; Q6ZN55; -.
DR   jPOST; Q6ZN55; -.
DR   MassIVE; Q6ZN55; -.
DR   MaxQB; Q6ZN55; -.
DR   PaxDb; Q6ZN55; -.
DR   PeptideAtlas; Q6ZN55; -.
DR   ProteomicsDB; 67982; -. [Q6ZN55-1]
DR   ProteomicsDB; 67983; -. [Q6ZN55-2]
DR   Antibodypedia; 30883; 68 antibodies from 21 providers.
DR   DNASU; 64763; -.
DR   Ensembl; ENST00000359044.5; ENSP00000351939.3; ENSG00000105732.13. [Q6ZN55-1]
DR   Ensembl; ENST00000600245.1; ENSP00000469029.1; ENSG00000105732.13. [Q6ZN55-1]
DR   GeneID; 64763; -.
DR   KEGG; hsa:64763; -.
DR   MANE-Select; ENST00000359044.5; ENSP00000351939.3; NM_022752.6; NP_073589.4.
DR   UCSC; uc002osk.6; human. [Q6ZN55-1]
DR   AGR; HGNC:26166; -.
DR   CTD; 64763; -.
DR   DisGeNET; 64763; -.
DR   GeneCards; ZNF574; -.
DR   HGNC; HGNC:26166; ZNF574.
DR   HPA; ENSG00000105732; Low tissue specificity.
DR   neXtProt; NX_Q6ZN55; -.
DR   OpenTargets; ENSG00000105732; -.
DR   PharmGKB; PA134916492; -.
DR   VEuPathDB; HostDB:ENSG00000105732; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000161799; -.
DR   HOGENOM; CLU_002678_24_1_1; -.
DR   InParanoid; Q6ZN55; -.
DR   OMA; CAKPFNS; -.
DR   OrthoDB; 5299235at2759; -.
DR   PhylomeDB; Q6ZN55; -.
DR   TreeFam; TF350791; -.
DR   PathwayCommons; Q6ZN55; -.
DR   SignaLink; Q6ZN55; -.
DR   BioGRID-ORCS; 64763; 548 hits in 1181 CRISPR screens.
DR   ChiTaRS; ZNF574; human.
DR   GenomeRNAi; 64763; -.
DR   Pharos; Q6ZN55; Tdark.
DR   PRO; PR:Q6ZN55; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q6ZN55; protein.
DR   Bgee; ENSG00000105732; Expressed in cerebellar vermis and 199 other tissues.
DR   ExpressionAtlas; Q6ZN55; baseline and differential.
DR   Genevisible; Q6ZN55; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 13.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24409:SF295; AZ2-RELATED; 1.
DR   PANTHER; PTHR24409; ZINC FINGER PROTEIN 142; 1.
DR   Pfam; PF00096; zf-C2H2; 5.
DR   Pfam; PF13894; zf-C2H2_4; 1.
DR   Pfam; PF13912; zf-C2H2_6; 2.
DR   Pfam; PF12874; zf-met; 1.
DR   SMART; SM00355; ZnF_C2H2; 20.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 11.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 18.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 19.
PE   1: Evidence at protein level;
KW   Alternative splicing; DNA-binding; Metal-binding; Methylation; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..896
FT                   /note="Zinc finger protein 574"
FT                   /id="PRO_0000274861"
FT   ZN_FING         16..38
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         76..98
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         126..148
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         214..236
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         309..331
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         336..358
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         364..386
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         392..413
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         466..489
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         495..517
FT                   /note="C2H2-type 10; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         523..545
FT                   /note="C2H2-type 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         551..573
FT                   /note="C2H2-type 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         579..601
FT                   /note="C2H2-type 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         607..630
FT                   /note="C2H2-type 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         636..659
FT                   /note="C2H2-type 15; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         667..689
FT                   /note="C2H2-type 16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         738..760
FT                   /note="C2H2-type 17"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         766..788
FT                   /note="C2H2-type 18"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         794..816
FT                   /note="C2H2-type 19"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         822..844
FT                   /note="C2H2-type 20"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          239..301
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          434..460
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          687..733
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        247..261
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        279..296
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         164
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:23186163"
FT   MOD_RES         298
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         717
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         724
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16964243"
FT   MOD_RES         728
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231"
FT   MOD_RES         832
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   VAR_SEQ         1
FT                   /note="M -> MPRATWANSKERSWAESERGPRDTGNGGSKAERHIQEIETGRGGDRA
FT                   KAHRRQRMRLRGTERASLGPGRRLGDSRGTDMPGARAQGLAAA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_022878"
FT   VARIANT         332
FT                   /note="R -> Q (in dbSNP:rs3745226)"
FT                   /id="VAR_030351"
FT   VARIANT         711
FT                   /note="T -> S (in dbSNP:rs35898322)"
FT                   /id="VAR_052870"
FT   VARIANT         785
FT                   /note="R -> Q (in dbSNP:rs3745228)"
FT                   /id="VAR_030352"
FT   CONFLICT        513
FT                   /note="H -> R (in Ref. 1; BAD18565)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        811
FT                   /note="E -> G (in Ref. 1; BAC11210)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   896 AA;  98900 MW;  F1E3EBCC47427654 CRC64;
     MTEESEETVL YIEHRYVCSE CNQLYGSLEE VLMHQNSHVP QQHFELVGVA DPGVTVATDT
     ASGTGLYQTL VQESQYQCLE CGQLLMSPSQ LLEHQELHLK MMAPQEAVPA EPSPKAPPLS
     SSTIHYECVD CKALFASQEL WLNHRQTHLR ATPTKAPAPV VLGSPVVLGP PVGQARVAVE
     HSYRKAEEGG EGATVPSAAA TTTEVVTEVE LLLYKCSECS QLFQLPADFL EHQATHFPAP
     VPESQEPALQ QEVQASSPAE VPVSQPDPLP ASDHSYELRN GEAIGRDRRG RRARRNNSGE
     AGGAATQELF CSACDQLFLS PHQLQQHLRS HREGVFKCPL CSRVFPSPSS LDQHLGDHSS
     ESHFLCVDCG LAFGTEALLL AHRRAHTPNP LHSCPCGKTF VNLTKFLYHR RTHGVGGVPL
     PTTPVPPEEP VIGFPEPAPA ETGEPEAPEP PVSEETSAGP AAPGTYRCLL CSREFGKALQ
     LTRHQRFVHR LERRHKCSIC GKMFKKKSHV RNHLRTHTGE RPFPCPDCSK PFNSPANLAR
     HRLTHTGERP YRCGDCGKAF TQSSTLRQHR LVHAQHFPYR CQECGVRFHR PYRLLMHRYH
     HTGEYPYKCR ECPRSFLLRR LLEVHQLVVH AGRQPHRCPS CGAAFPSSLR LREHRCAAAA
     AQAPRRFECG TCGKKVGSAA RLQAHEAAHA AAGPGEVLAK EPPAPRAPRA TRAPVASPAA
     LGSTATASPA APARRRGLEC SECKKLFSTE TSLQVHRRIH TGERPYPCPD CGKAFRQSTH
     LKDHRRLHTG ERPFACEVCG KAFAISMRLA EHRRIHTGER PYSCPDCGKS YRSFSNLWKH
     RKTHQQQHQA AVRQQLAEAE AAVGLAVMET AVEALPLVEA IEIYPLAEAE GVQISG
//
